NFA
ANAB icon

Nationwide Fund Advisors’s AnaptysBio ANAB Stock Holding History

Nationwide Fund Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,878
Closed -$205K – 116
2017
Q3 		$205K Buy
5,878
+2,776
+89% +$74.9K ﹤0.01% 2631
2017
Q2 		$74K Buy
3,102
+1,688
+119% +$42.4K ﹤0.01% 2998
2017
Q1 		$0 Buy
+1,414
New +$32.9K ﹤0.01% 3193

Other funds holding ANAB

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nationwide Fund Advisors's ANAB Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of AnaptysBio (ANAB) in Q4 2017, closing a stake of 5,878 shares — an estimated $205K sold.

Nationwide Fund Advisors first reported a position in ANAB in Q1 2017 and held it in 3 quarters. The position peaked at $205K in Q3 2017. 116 funds tracked by Wall St. Rank hold ANAB as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining AnaptysBio position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 5,878 AnaptysBio shares in Q4 2017, an estimated $205K.
  • Nationwide Fund Advisors first reported a position in AnaptysBio in Q1 2017 and held it in 3 quarters.
  • Nationwide Fund Advisors's AnaptysBio position peaked at $205K in Q3 2017.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.